x



Share this page.

Submit to Scientific Poster and Platform Sessions

The scientific quality of the abstracts presented at the SOT Annual Meeting and ToxExpo contributes substantially towards making the event the leading international forum for new toxicological research. SOT solicits abstracts for poster and platform sessions from mid-August to October 7 each year (if October 7 falls on a Saturday or Sunday, the deadline for abstracts is October 9 at 12:00 Noon Eastern Time).

Abstracts for the 2017 Annual Meeting were accepted between August 15 and October 7, 2016. Late-breaking abstracts were accepted from December 5, 2016 to January 12, 2017.

Please reference the Society’s abstract submission FAQ for additional information regarding the process.

Open All
Close All
Why Submit an Abstract?
  • Contribute your toxicologic research to the leading international forum for toxicologists.
  • Present cutting-edge research that could potentially have a significant impact on the practice of toxicology.
  • Provide attendees with the opportunity to learn about emerging fields and how they apply to toxicology.
  • Open dialogue among your scientific colleagues to effectively develop strategies for active involvement in other areas of toxicology.
  • Gain recognition among your peers by having your research published in The Toxicologist.
Submission Timeline and Instructions

The Scientific Program Committee requires electronic submission of all abstracts. The regular deadline to submit an abstract is October 7 (October 9 if October 7 falls on a Saturday or Sunday) in any calendar year. The fee for submission is $50. The system is designed for those who will be paying their abstract fee by credit card and who have access to the internet. All submissions can be entered until 11:59 pm (Eastern Time) on October 7 (or 12:00 Noon Eastern Time on October 9, only if October 7 falls on a Saturday or Sunday). The site will typically re-open for Late Breaking submissions in early December.

  • The Scientific Program Committee requires electronic submission of all abstracts. The deadline to submit an abstract is October 7 in any calendar year (October 9 if October 7 falls on a Saturday or Sunday). The fee for submission is $50. The system is designed for those who will be paying their abstract fee by credit card and who have access to the internet. All submissions can be entered until 11:59 pm (Eastern Time) on October 7, or 12:00 Noon (Eastern Time) on October 9, if October 7 falls on a Saturday or Sunday.
  • If there are opportunities for the submission of late-breaking abstracts, additional information will be available from SOT Headquarters.
  • A confirmation/receipt page is provided online; please print a copy for your records.
  • Written notification of withdrawal of an abstract must be received at SOT Headquarters by October 10 each year prior to review by the Scientific Program Committee. Abstracts may not be changed or withdrawn once accepted by the Scientific Program Committee. If circumstances prevent attendance, the author must arrange for the paper to be given by a substitute. Acceptance of the abstract by the Committee obligates the author to present the paper and pay the meeting registration fee.
  • You will receive your acceptance notice and session instructions in early December. The complexity of the program planning process prevents any changes in the type of session, time, or location of presentation. There are no exceptions. PowerPoint presentations that are PC compatible are required for platform presentations.
  • Please reference the Society’s abstract submission FAQ for additional information regarding the process.
Authorship/Sponsorship Guidelines
  • Authors are permitted as presenting author on only one abstract for the meeting, which includes invited presentations for scientific sessions. There is no restriction to the number of co-authorships or sponsorships.
  • The SOT Scientific Program Committee reserves the right to require consolidation of multiple abstracts submitted from a single study. Each abstract selected for the program must be presented by the presenting author.
  • If none of the authors is a member of the SOT, sponsorship by a Full or Associate SOT member is required. By sponsoring the abstract, the sponsor acknowledges that the research has been done according to the SOT Code of Ethics.
  • SOT members may sponsor an unlimited number of abstracts.
Content Rules and Guidelines

The Scientific Program Committee reviews each abstract that is submitted. The scientific quality of the abstracts presented contributes substantially towards making the SOT Annual Meeting the leading international forum for new toxicologic research. As such, there is a standard for abstract acceptance. While rejection is always unfortunate, abstracts are archived materials that are often cited as publications and the quality of the science presented at the Annual Meeting is paramount. The following guidelines apply:

  1. The abstract cannot be more than 2,300 total characters. This includes the title, body, author last name, institutions. Spaces are not included in the 2,300 count.
  2. The abstract may not contain tables, figures or chemical structures.
  3. Define all nonstandard acronyms.
  4. All presenters for programmed abstracts agree to accept the assigned time slot.
  5. All presenters are responsible for registering for the Annual Meeting and paying the registration fee.

Abstracts describing the results of experimental studies must answer two questions: “What was done?” and “What was found?” Abstracts must contain the following:

  1. A statement of the rationale and scope of the study presented;
  2. A brief description of the experimental procedures;
  3. The data that resulted from the study; and
  4. Principal conclusion(s) based on interpretation of the results.

Test compounds utilized in the study should be identified in the abstract. In cases where the length of the proper chemical name precludes its use, a manufacturer’s identification number, etc., may be acceptable, provided the structure and chemical identity of the compound is included in the presentation.

Abstracts will not be accepted if the authors are unable to disclose the chemical identity of the compound(s) used in the study.

Phrases such as “results/data will be discussed” convey no information as to the outcome of the studies and are unacceptable.

It can be challenging to describe results of “big data” studies in the confines of a 2,300 character abstract. The Society recommends inclusion of specific examples of findings to help meet the requirement for description of data.

All animal experimentation must be carried out in accordance with the Society’s criteria for the care and use of animals in research. Review the Guiding Principles in the Use of Animals in Toxicology here.

All abstracts submitted with human testing require that IRB protocol has been followed and approval obtained.

In the case of studies that do not describe laboratory or field experiments, such as reports on educational, ethics, legal, or social initiatives, all the guidelines above apply with the following modifications:

  1. Instead of experimental procedures, the research or assessment approach should be briefly described;
  2. Instead of resultant data, the study’s results or findings should be summarized explicitly; and
  3. These abstracts must clearly articulate the implications for stakeholders.

Abstracts describing new initiatives or science policy in the regulatory community must clearly describe the impact on practice of toxicology and/or risk assessment.

Care should be taken to clearly distinguish between statements based on documented facts vs. opinions. Literature surveys or reviews and background materials are insufficient in and of themselves.

Call for Education Abstracts   PDF icon

Category List

The general submission categories listed below are one tool used by the Scientific Program Committee to program abstracts. All abstracts are reviewed and may be programmed into subcategories in the creation of Annual Meeting sessions. This list, which is available within the submission site, is current as of June 2016. It is subject to change without notice.

Air Pollution Toxicology
Alternatives to Mammalian Models
Animal Models
Autoimmunity/Hypersensitivity
Bioinformatics
Biological Modeling
Biomarkers
Biotransformation/Cytochrome P450
Carcinogenesis
Cardiovascular Toxicology/Hemodynamics
Cell Death/Apoptosis
Chemical and Biological Weapons
Clinical and Translational Toxicology
Computational Toxicology and Data Integration
Developmental and Juvenile Toxicology
Developmental Basis of Adult Disease
Disposition/Pharmacokinetics
Ecotoxicology
Education, Ethical, Legal and Social Issues
Emerging Technologies
Endocrine Toxicology
Epidemiology and Public Health
Epigenetics
Exposure Assessment/Biomonitoring
Food Safety/Nutrition
Gene Regulation/Signal Transduction
Genotoxicity/DNA Repair
Immunotoxicity
Inflammation in Disease
Inflammation: Methods and Mechanisms
Inhalants
Kidney
Liver
Medical Devices
Metals
Mixtures
Nanotoxicology, Carbon-Based Nanomaterials
Nanotoxicology, Exposure, Dosimetry, and In Silico
Nanotoxicology, General
Nanotoxicology, In Vitro
Nanotoxicology, In Vivo
Natural Products
Neurodegenerative Disease
Neurotoxicity, Developmental
Neurotoxicity, General
Neurotoxicity, Metals
Neurotoxicity, Pesticides
Ocular Toxicology
Oxidative Injury and Redox Biology
Persistent Organic Pollutants (POPs)
Pesticides
Pharmacogenomics/Genetic Polymorphisms
Receptors
Regulation/Policy
Reproductive Toxicology
Respiratory Toxicology
Risk Assessment
Safety Assessment: Non-Pharmaceutical
Safety Assessment: Pharmaceutical-Drug Development
Safety Assessment: Pharmaceutical-Drug Discovery
Skin
Stem Cell Biology and Toxicology
Systems Biology and Toxicology